Translocation-Related Sarcomas

Fredrik Mertens, Cristina R. Antonescu, Peter Hohenberger, Marc Ladanyi, Piergiorgio Modena, Maurizio D'Incalci, Paolo G. Casali, Massimo Aglietta, Thor Alvegård

Research output: Contribution to journalArticle


Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.

Original languageEnglish
Pages (from-to)312-323
Number of pages12
JournalSeminars in Oncology
Issue number4
Publication statusPublished - Aug 2009


ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Mertens, F., Antonescu, C. R., Hohenberger, P., Ladanyi, M., Modena, P., D'Incalci, M., Casali, P. G., Aglietta, M., & Alvegård, T. (2009). Translocation-Related Sarcomas. Seminars in Oncology, 36(4), 312-323.